Backed by successful biotech ventures with measurable returns and sustainable impact.
Every opportunity is vetted through our expert scientific, regulatory, and commercial review committees.
Investing with OBH means contributing to the Gulf’s growing life sciences infrastructure and innovation ecosystem.
OBH’s investment framework aligns scientific breakthroughs with financial discipline — creating shared value and de-risked growth.
Curated biotech ventures screened for innovation, scalability, and intellectual property strength.
Flexible partnership and equity models aligned with investor objectives and portfolio goals.
Transparent performance tracking and milestone-based funding for data-driven investment decisions.
Planned exit pathways via licensing, M&A, or IPO — maximizing returns with reduced risk.
Pioneering plasma collection and PDMP platforms across the GCC
Expanding regional biologics manufacturing and R&D capabilities
Advancing regenerative medicine through cord blood banking